Search clinical trials for: Chorea

Total 257 results

Assistance Publique - Hôpitaux de Paris
Euromov Digital Health in Motion Montpellier France

Completed

Adapted Physical Activity Effect on Abilities and Quality of Life of Huntington Patients and Relatives During Rehab Stay (HUNT'ACTIV)

Huntington Disease

France
Annexon, Inc.

Completed

An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease

Huntington Disease

United States
Hoffmann-La Roche

Completed

A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease

Huntingtons Disease

United Kingdom, Netherlands
Universitaire Ziekenhuizen KU Leuven
CHDI Foundation, Inc.

Completed

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Huntington Disease

Belgium
Saccadous, Inc.
Barrow Neurological Institute; Dignity Health

Completed

Complex Eye Movements in Parkinson's Disease and Related Movement Disorders

Parkinson Disease | Parkinsonian Disorders | Corticobasal Degeneration | Progressive Supranuclear Palsy | Huntington Disease | Essential Tremor | Parkinson's Disease and Parkinsonism | Vascular Parkinsonism | Parkinsonian Syndrome | Multiple System Atrophy, Parkinson Variant

United States
Vaccinex Inc.
Huntington Study Group

Completed

A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi (SIGNAL-HD)

Huntington's Disease

United States, Canada
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease (PRECISION-HD2)

Huntington's Disease

United States, Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
University Hospitals Cleveland Medical Center
National Institute of Neurological Disorders and Stroke (NINDS); The Cleveland... and other collaborators

Completed

Mitochondrial Biomarkers in Huntington's Disease

Huntington Disease

United States
EIP Pharma Inc
Voisin Consulting, Inc.

Terminated

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

Huntington Disease

United Kingdom
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)

Huntington's Disease

Germany, Canada, United Kingdom
Hospital Universitario de Burgos
La Caixa Foundation; Universidad Isabel I

Completed

Energy Balance in Huntington's Disease. A Multidisciplinary Study Approach for a Complex Problem (BEHD-EM) (BEHD-EM)

Huntington Disease

Spain
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (PRECISION-HD1)

Huntington's Disease

Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Prilenia

Completed

Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease (OPEN-HART)

Huntington Disease
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Sage Therapeutics

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B

Huntington Disease

United States
Heinrich-Heine University, Duesseldorf
Medtronic; The George Institute; KKS Netzwerk; CHDI Foundation, Inc.; Egyptian Society...

Completed

Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) (HD-DBS)

Huntington Disease

Austria, Germany, France, Switzerland
Johns Hopkins University

Completed

Group Drum-Based Music Therapy Intervention for Parkinson's Disease/Huntington's Disease

Parkinson Disease | Huntington Disease

United States
Prilenia

Completed

A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease

Health Volunteers, Huntington Disease

Germany
Auspex Pharmaceuticals, Inc.

Completed

Alternatives for Reducing Chorea in Huntington Disease (ARC-HD)

Chorea Associated With Huntington Disease

United States, Australia, Canada
Hoffmann-La Roche

Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

Huntington's Disease

United Kingdom, United States, Germany, Canada
Prilenia

Terminated

A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease (Open PRIDE-HD)

Huntington's Disease

United States, Australia, Austria, Canada, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
Institut National de la Santé Et de la Recherche...
Ultragenyx Pharmaceutical Inc

Completed

A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (TRIHEP3)

Huntington Disease

France, Netherlands
Voyager Therapeutics

Withdrawn

Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease

Huntington Disease
Anne Kloos

Completed

The Effect of Video Game Exercise on Dynamic Balance and Gait in Individuals With Huntington's Disease

Huntington's Disease

United States
Prilenia
Huntington Study Group; European Huntington's Disease Network

Completed

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Huntington's Disease

United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
University Hospital, Montpellier
Agence de La Biomédecine

Active, not recruiting

NIPD on cffDNA for Triplet Repeat Diseases

Fragile X Syndrome | Huntington Disease | Myotonic Dystrophy 1

France
Jody Corey-Bloom, MD, PhD
Forest Laboratories

Completed

Study of Memantine to Treat Huntington's Disease

Huntington's Disease

United States
University Hospital, Angers

Completed

Assessment of the Psychological, Cognitive and Social Resources of Applicants for Huntington's Disease and Presymptomatic Genetic Testing (PREHUNT)

Presymptomatic Huntington Disease

France
University Hospital, Angers

Completed

Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging (COSIMH)

Huntington's Disease

France
University Hospital, Angers

Terminated

Behavioural Problems in Huntington Disease : Analysis and Enhancement of Caregiver and Patient Experience (HUNTEXPERT)

Huntington Disease

France
Children's Hospital of Philadelphia
Ilera Healthcare

Terminated

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products (Ilera)

Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Parkinson Disease | HIV/AIDS | ALS | Autism Spectrum Disorder | Sickle Cell Disease | Spasticity, Muscle | Huntington Disease | Opioid Use | Neuropathy | Terminal Illness | Inflammatory Bowel Disease (IBD) | Intractable Pain | Ptsd | Dyskinetic Syndrome

United States
Centre Hospitalier Universitaire, Amiens

Completed

Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI) (ISDC)

Alzheimer Disease | Frontotemporal Dementia | Dementia, Vascular | Semantic Dementia | Huntington Disease

France
University Hospital, Angers

Unknown

Skills of Home Helpers for a Better Quality of Life for Adults With Huntington's Disease Living at Home (COMPQUAHD)

Quality of Life
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod (LEGATO-HD)

Huntington's Disease

United States, Canada, Czechia, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, United Kingdom
CHDI Foundation, Inc.

Unknown

Development of Assessments for Later Stage HD (LSA)

Huntington Disease

United States, United Kingdom
Massachusetts General Hospital
ALS Association

Completed

Electronic-health Application To Measure Outcomes REmotely Clinical Trial (EAT MORE)

Parkinson's Disease | Amyotrophic Lateral Sclerosis | Weight Loss | Cachexia | Huntington's Disease | Neurodegenerative Disease

United States
Chong Kun Dang Pharmaceutical

Unknown

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Huntington Disease

Korea, Republic of
Georgetown University

Unknown

Nilotinib in Huntington's Disease (Tasigna HD)

Huntington Disease

United States
Institut National de la Santé Et de la Recherche...
University College, London

Completed

Decoding Presymptomatic White Matter Changes in Huntington Disease (Win-HD)

Huntington Disease | White Matter Alterations

France
Assistance Publique - Hôpitaux de Paris

Completed

Resveratrol and Huntington Disease (REVHD)

Huntington Disease

France
Birmingham and Solihull Mental Health NHS Foundation...
University of Birmingham

Completed

Brain Stimulation in Movement Disorders

Tourette Syndrome | Huntington's Disease

United Kingdom
University of British Columbia
Huntington Study Group; Huntington Society of Canada

Completed

A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease (MITIGATE-HD)

Huntington Disease

Canada
Lancaster University
Manchester University NHS Foundation Trust

Completed

A Pilot Evaluation of Mindfulness-based Cognitive Therapy for People With Huntington's Disease

Huntington Disease

United Kingdom
Cardiff University
CHDI Foundation, Inc.

Unknown

PHysical Activity and Exercise Outcomes in Huntington's Disease (PACE-HD)

Huntington Disease

Spain, Germany, United States
CHDI Foundation, Inc.
Dr. Glenn T. Stebbins (Rush University Medical Center ); Dr. Nancy LaPelle

Completed

FuRST 2.0 Cognitive Pre-testing - Round 2

Huntington Disease

United States, Canada
Centre Hospitalier Universitaire, Amiens

Terminated

Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies (GREFEXII)

Stroke | Parkinson Disease | Alzheimer Disease | Traumatic Brain Injury | Huntington Disease | Frontal Dementia

France
CHDI Foundation, Inc.

Completed

Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers (LONGPDE10)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
SOM Innovation Biotech SA

Completed

Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

Huntington's Chorea

Spain
Shaare Zedek Medical Center
University of Oklahoma

Unknown

Dopaminergic Receptors in Sydenham's Chorea

Strep Throat | Sydenham Chorea

Israel

Search clinical trials for: Chorea

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations